Clinical Trials Search | Clareo Health

About Pricing FAQs Blog

Loading clinical trials...

Clareo Health

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 1-2 of 2 trials

RECRUITINGPhase 3

A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

NCT07285304

A clinical study to evaluate the long-term safety and efficacy of TS-172 in hyperphosphatemia patients on hemodialysis.

Hyperphosphatemia Patients on Hemodialysis

Taisho Pharmaceutical Co., Ltd.300 participantsStarted Dec 2025

Tokyo, Japan

COMPLETEDPhase 2

A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

NCT05699239

A phase 2, randomized, placebo-controlled, double-blind, dose-finding study of TS-172 in hyperphosphatemia patients on hemodialysis

Hyperphosphatemia Patients on Hemodialysis

Taisho Pharmaceutical Co., Ltd.326 participantsStarted Feb 2023

Tokyo, Japan

Data from ClinicalTrials.govTerms

Showing 1-2 of 2 trials

RECRUITINGPhase 3

A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

NCT07285304

A clinical study to evaluate the long-term safety and efficacy of TS-172 in hyperphosphatemia patients on hemodialysis.

Hyperphosphatemia Patients on Hemodialysis

Taisho Pharmaceutical Co., Ltd.300 participantsStarted Dec 2025

Tokyo, Japan

COMPLETEDPhase 2

A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

NCT05699239

A phase 2, randomized, placebo-controlled, double-blind, dose-finding study of TS-172 in hyperphosphatemia patients on hemodialysis

Hyperphosphatemia Patients on Hemodialysis

Taisho Pharmaceutical Co., Ltd.326 participantsStarted Feb 2023

Tokyo, Japan

Data from ClinicalTrials.govTerms